Skip to main content
. 2019 May-Jun;45(3):e20170351. doi: 10.1590/1806-3713/e20170351

Table 2. Contamination profile of home nebulizers of cystic fibrosis patients: type of fungus and bacteria according to place of contamination.

Characteristics Interface Cup Any part of the device
N (%) 95%CI N (%) 95%CI N (%) 95%CI
Any contamination 45 (60.8) 49.7 - 71.9 46 (62.2) 51.2 - 73.2 53 (71.6) 61.3 - 81.9
Bacterial contamination 35 (47.3) 35.9 - 58.7 37 (50.0) 38.6 - 61.4 42 (56.8) 45.5 - 68.1
Gram-negative bacteriaa 25 (71.4) 56.4 - 86.4 23 (62.2) 46.6 - 77.8 36 (85.7) 75.1 - 96.3
Pseudomonas spp.a 5 (14.3) 2.7 - 25.9 9 (24.3) 10.5 - 38.1 13 (31.0) 17.0 - 45.0
Non-mucoid Pseudomonas aeruginosa a -- -- 2 (5.4) 0.0 - 12.7 2 (4.8) 0.0 - 11.3
Mucoid Pseudomonas aeruginosa a -- -- -- -- -- --
Other Pseudomonas a 5 (14.3) 2.7 - 25.9 7 (18.9) 6.3 - 31.5 10 (23.8) 10.9 - 36.7
Acinetobacter spp.a 8 (22.9) 9.0 - 36.8 7 (18.9) 6.3 - 31.5 9 (21.4) 9.0 - 33.8
Stenotrophomonas spp.a 5 (14.3) 2.7 - 25.9 4 (10.8) 0.8 - 20.8 5 (11.9) 2.1 - 21.7
Stenotrophomonas maltophilia a 5 (14.3) 2.7 - 25.9 4 (10.8) 0.8 - 20.8 5 (11.9) 2.1 - 21.7
Enterobacter spp.a 3 (8.6) 0.0 - 17.9 4 (10.8) 0.8 - 20.8 4 (11.9) 2.1 - 21.7
Klebsiella spp.a 1 (2.9) 0.0 - 8.5 4 (10.8) 0.8 - 20.8 4 (9.5) 0.6 - 18.4
Sphingobacterium spp.a 1 (2.9) 0.0 - 8.5 1 (2.7) 0.0 - 7.9 2 (4.8) 0.0 - 11.3
Delftia spp.a 1 (2.9) 0.0 - 8.5 2 (5.4) 0.0 - 12.7 2 (4.8) 0.0 - 11.3
Burkholderia spp.a -- -- 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 -7.0
Burkholderia cepacia complexa -- -- 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 -7.0
Othera 12 (34.3) 18.6 - 50.0 9 (24.3) 10.5 - 38.1 15 (35.7) 21.2 - 50.2
Chryseobacterium indologenes a 5 (14.3) 2.7 - 25.9 4 (10.8) 0.8 - 20.8 5 (11.9) 2.1 - 21.7
Sphingomonas paucimobilis a 2 (5.7) 0.0 - 13.4 1 (2.7) 0.0 - 7.9 3 (7.1) 0.0 - 14.9
Pantoea agglomerans a 1 (2.9) 0.0 - 8.5 1 (2.7) 0.0 - 7.9 2 (4.8) 0.0 - 11.3
Aeromonas hydrophila a 1 (2.9) 0.0 - 8.5 -- -- 1 (2.4) 0.0 - 7.0
Comamonas testosteron a -- -- 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 - 7.0
Moraxella osloensis a 1 (2.9) 0.0 - 8.5 -- -- 1 (2.4) 0.0 - 7.0
Rhizobium radiobacter a 1 (2.9) 0.0 - 8.5 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 - 7.0
Serratia marcescens a 1 (2.9) 0.0 - 8.5 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 - 7.0
Gram-positive bacteriaa 10 (28.6) 13.6 - 43.6 10 (27.0) 12.7 - 41.3 17 (40.5) 25.7 - 55.3
Staphylococcus spp.a 6 (17.1) 4.6 - 29.6 7 (18.9) 6.3 - 31.5 9 (21.4) 9.0 - 33.8
Staphylococcus aureus a 2 (5.7) 0.0 - 13.4 2 (5.4) 0.0 - 12.7 2 (4.8) 0.0 - 11.3
Oxacillin-resistant coagulase-negative Staphylococcus aureus a 1 (2.9) 0.0 - 8.5 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 - 7.0
Other Staphylococcus a 3 (8.6) 0.0 - 17.9 4 (10.8) 0.8 - 20.8 6 (14.3) 3.7 - 24.9
Micrococcus spp.a 4 (11.4) 0.9 - 21.9 4 (10.8) 0.8 - 20.8 6 (14.3) 3.7 - 24.9
Bacillus spp.a 3 (8.6) 0.0 - 17.9 4 (10.8) 0.8 - 20.8 5 (11.9) 2.1 - 21.7
Streptococcus spp.a -- -- 1 (2.7) 0.0 - 7.9 1 (2.4) 0.0 - 7.0
Fungal contamination 20 (27.0) 16.9 - 37.1 28 (37.8) 26.8 - 48.8 34 (45.9) 34.5 - 57.3
Candida spp.b 11 (55.0) 33.2 - 76.8 14 (50.0) 31.5 - 68.5 18 (52.9) 36.1 - 69.7
Non-albicans Candida spp.b 9 (45.0) 23.2 - 66.8 14 (50.0) 31.5 - 68.5 16 (47.1) 30.3 - 63.9
Candida albicans b 1 (5.0) 0.0 - 14.6 -- -- 1 (2.9) 0.0 - 8.5
Candida spp.b 1 (5.0) 0.0 - 14.6 -- -- 1 (2.9) 0.0 - 8.5
Environmental contaminant fungusb 4 (20.0) 2.5 - 37.5 8 (28.6) 11.9 - 45.3 9 (26.5) 11.7 - 41.3
Otherb 7 (35.0) 14.1 - 55.9 7 (25.0) 9.0 - 41.0 10 (29.4) 14.1 - 44.7
Cladosporium sp.b 3 (15.0) 0.0 - 30.6 3 (10.7) 0.0 - 22.1 4 (11.8) 1.0 - 22.6
Rhodotorula spp.b 3 (15.0) 0.0 - 30.6 3 (10.7) 0.0 - 22.1 4 (11.8) 1.0 - 22.6
Aspergillus niger b -- -- 1 (3.6) 0.0 - 10.5 1 (2.9) 0.0 - 8.5
Penicillium sp.b 1 (5.0) 0.0 - 14.6 -- -- 1 (2.9) 0.0 - 8.5
a

Proportion calculated among number of interfaces (N=35), cups (N=37) and any part of nebulizer (N=42) with bacterial contamination. bProportion calculated among number of interfaces (N=20), cups (N=28) and any part of nebulizer (N=34) with bacterial contamination.